Spire Cambridge Lea Hospital Breast Surgeons cancer study wins international award

Spire Cambridge Lea Hospital Breast Surgeons at Anglia Ruskin receive recognition for research into sentinel lymph node biopsies

Two surgeons at Anglia Ruskin University and Spire Cambridge Lea Hospital have received a major international award for their study into a new method of carrying out breast cancer biopsies, which is both safer and cheaper than current practices.

Gordon Wishart, Professor of Cancer Surgery, and John Benson, Visiting Professor of Applied Surgical Sciences, won the B Braun Scientific Award at the 48th Conference of the European Society for Surgical Research in Istanbul.  The award is presented annually to the best new surgical technique or surgical device.

Affiliated to Anglia Ruskin’s Postgraduate Medical Institute, Professor Wishart and Professor Benson demonstrated how the use of fluorescent indocyanine green (ICG), detected by a PhotoDynamic Eye (PDE) camera, is more effective than radioisotope for carrying out sentinel lymph node biopsies for patients with breast cancer, particularly when used in conjunction with blue dye. 

Professor Wishart said: “In early breast cancer, keeping the number of false-negative biopsies and the number of excised sentinel lymph nodes to a minimum is essential.   

“Our study showed that the sensitivity for fluorescent ICG and blue dye [95.0%] compares very favourably with that for blue dye and radioisotope [73.1%] and suggests that a dual tracer approach using ICG and blue dye may be a potential way forward for sentinel lymph node detection. 

“Fluorescent ICG has been used in several aspects of healthcare for many years and is safe, cheap and readily available in all hospitals.  In contrast, radioisotope is expensive and requires access to nuclear medicine facilities, and therefore involves potential radiation exposure for patients and staff.  

“Furthermore, there are now international shortages of radioisotope which is likely to lead to increased cost in the future.  Because of the cost implications, ICG is more likely to be adopted in developing countries.  It is also a much easier technique to teach surgical trainees and, most importantly, it is extremely successful at detecting the first sentinel lymph node.”

The study was carried out at the Cambridge Breast Unit at Addenbrooke’s Hospital, where Professor Benson is a Consultant Breast Surgeon, and was published in the European Journal of Surgical Oncology.  Further research studies involving fluorescent ICG are now under way examining sentinel lymph node biopsies in anal cancer and melanoma.

Breast care at Spire Cambridge Lea Hospital

Spire Cambridge Lea Hospital has a rapid access breast clinic that specialises in the diagnosis and treatment of breast cancer and related breast problems. At the clinic you will have access to specialist diagnostic facilities, surgeons and radiologists. The leading private health insurance company, BUPA, has accredited the hospital as a breast care centre of excellence.
Click here to read more

 

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Women's Health at Spire Cambridge Lea Hospital

Click here for more about our women's health services

© Spire Healthcare Group plc (2016)